Headache medicine is a specialized field within neurology focusing on the diagnosis and treatment of primary and secondary headache disorders, including migraine, cluster headache, and tension-type headache. Chronic headaches are among the most disabling neurological conditions, significantly impacting quality of life and productivity.

The Headache Medicine session provides a comprehensive exploration of headache pathophysiology, neurovascular mechanisms, and emerging therapeutic strategies. Scientists examine cortical spreading depression, trigeminovascular activation, and genetic factors contributing to recurrent pain syndromes.

At the Headache Medicine Conference, neurologists and pain specialists present updates on neuroimaging, novel pharmacologic agents, and non-invasive neuromodulation therapies. Discussions highlight monoclonal antibodies targeting CGRP, serotonin receptor modulators, and behavioral interventions for migraine management.

This session caters to clinicians, researchers, and healthcare professionals aiming to integrate evidence-based treatments and improve diagnostic accuracy. Focus areas include gender-specific prevalence, lifestyle triggers, and comorbidities such as anxiety, sleep disturbances, and hormonal fluctuations.

New research in Pain Mechanisms is uncovering molecular pathways that bridge migraine pathology with sensory processing, offering promising directions for personalized headache therapy.